$TBTC
TABLE TRAC INC

2022 Q4 Form 10-Q Financial Statement

#000143774922026747 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $2.944M $2.301M $1.450M
YoY Change 55.56% 58.73% 21.98%
Cost Of Revenue $977.1K $865.7K $407.2K
YoY Change 40.65% 112.61% 29.51%
Gross Profit $1.967M $1.436M $1.043M
YoY Change 64.21% 37.68% 19.27%
Gross Profit Margin 66.81% 62.38% 71.92%
Selling, General & Admin $1.426M $1.094M $754.0K
YoY Change 54.45% 45.03% -10.64%
% of Gross Profit 72.5% 76.17% 72.31%
Research & Development $190.7K $0.00
YoY Change
% of Gross Profit 9.69% 0.0%
Depreciation & Amortization $0.00 $1.980K $6.290K
YoY Change -100.0% -68.52% -34.82%
% of Gross Profit 0.0% 0.14% 0.6%
Operating Expenses $1.617M $1.094M $754.0K
YoY Change 75.1% 45.03% -10.64%
Operating Profit $350.3K $342.1K $288.7K
YoY Change 27.56% 18.49% 848.76%
Interest Expense $62.99K $26.51K -$45.42K
YoY Change 439.76% -158.37% -503.37%
% of Operating Profit 17.98% 7.75% -15.73%
Other Income/Expense, Net $0.00 $0.00 -$57.00K
YoY Change -100.0% -100.0%
Pretax Income $413.3K $368.6K $243.3K
YoY Change -45.6% 51.5% 483.55%
Income Tax $98.50K $78.50K $56.50K
% Of Pretax Income 23.83% 21.3% 23.22%
Net Earnings $314.8K $290.1K $186.8K
YoY Change -58.26% 55.3% 532.98%
Net Earnings / Revenue 10.69% 12.61% 12.88%
Basic Earnings Per Share $0.06 $0.04
Diluted Earnings Per Share $0.07 $0.06 $0.04
COMMON SHARES
Basic Shares Outstanding 4.622M 4.622M 4.512M
Diluted Shares Outstanding 4.567M 4.526M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.846M $4.715M $4.402M
YoY Change -2.79% 7.11% 125.19%
Cash & Equivalents $4.787M $4.674M $4.360M
Short-Term Investments $59.17K $41.18K $41.91K
Other Short-Term Assets $417.3K $410.9K $187.7K
YoY Change -47.81% 118.88% 38.05%
Inventory $1.560M $1.781M $1.607M
Prepaid Expenses $417.3K $410.9K $187.7K
Receivables $1.868M $1.799M $1.435M
Other Receivables $124.2K $82.63K $0.00
Total Short-Term Assets $8.816M $8.788M $7.632M
YoY Change 5.15% 15.15% 26.1%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $10.83K
YoY Change -100.0% -100.0% -72.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $176.4K $106.2K $147.4K
YoY Change 28.47% -27.93%
Other Assets $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $1.858M $1.148M $526.4K
YoY Change 201.15% 118.14% -75.44%
TOTAL ASSETS
Total Short-Term Assets $8.816M $8.788M $7.632M
Total Long-Term Assets $1.858M $1.148M $526.4K
Total Assets $10.67M $9.937M $8.159M
YoY Change 18.58% 21.79% -0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $417.9K $371.8K $289.7K
YoY Change 61.48% 28.34% 160.19%
Accrued Expenses $66.61K $80.16K $99.10K
YoY Change -13.96% -19.11% -23.14%
Deferred Revenue $1.486M $1.267M $1.008M
YoY Change -5.73% 25.7% 525.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.970M $1.719M $1.791M
YoY Change -16.17% -4.04% 157.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $473.4K
YoY Change -100.0% 154.77%
Other Long-Term Liabilities $97.48K $113.8K $135.8K
YoY Change -21.46% -16.22% -93.76%
Total Long-Term Liabilities $97.48K $113.8K $473.4K
YoY Change -21.46% -75.97% 154.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.970M $1.719M $1.791M
Total Long-Term Liabilities $97.48K $113.8K $473.4K
Total Liabilities $2.399M $2.024M $2.429M
YoY Change -3.06% -16.7% -29.48%
SHAREHOLDERS EQUITY
Retained Earnings $6.298M $6.078M $4.014M
YoY Change 32.07% 51.41% 28.57%
Common Stock $2.212M $2.069M $1.949M
YoY Change 10.99% 6.16% 3.98%
Preferred Stock
YoY Change
Treasury Stock (at cost) $233.6K $233.6K $233.6K
YoY Change 0.0% 0.0% -4.9%
Treasury Stock Shares $134.7K $134.7K $134.7K
Shareholders Equity $8.276M $7.913M $5.729M
YoY Change
Total Liabilities & Shareholders Equity $10.67M $9.937M $8.159M
YoY Change 18.58% 21.79% -0.45%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $314.8K $290.1K $186.8K
YoY Change -58.26% 55.3% 532.98%
Depreciation, Depletion And Amortization $0.00 $1.980K $6.290K
YoY Change -100.0% -68.52% -34.82%
Cash From Operating Activities $208.1K $311.4K $792.1K
YoY Change -64.47% -60.69% 77.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -95.11K 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 208.1K 311.4K 792.1K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -95.11K 0.000 0.000
Net Change In Cash 113.0K 311.4K 792.1K
YoY Change -80.71% -60.69% 77.22%
FREE CASH FLOW
Cash From Operating Activities $208.1K $311.4K $792.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56786 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61376 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4756734
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4621988
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4521988
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
134746
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
134746
CY2022Q3 tbtc Number Of Contracts Of Collectable Revenue
NumberOfContractsOfCollectableRevenue
1 usd
CY2021Q1 us-gaap Lessor Sales Type Lease Term Of Contract1
LessorSalesTypeLeaseTermOfContract1
P5Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
us-gaap Open Tax Year
OpenTaxYear
2017 2018 2019 2020
CY2022Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32987
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0336568
dei Entity Address Address Line1
EntityAddressAddressLine1
6101 Baker Road, Suite 206
dei Entity Address City Or Town
EntityAddressCityOrTown
Minnetonka
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55345
dei City Area Code
CityAreaCode
952
dei Local Phone Number
LocalPhoneNumber
548-8877
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4621988
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4673958 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4945913 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1799184 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1017533 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1780571 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1582358 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
410859 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
799524 usd
CY2022Q3 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
41176 usd
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39369 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
82627 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
8788375 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8384697 usd
CY2022Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
869819 usd
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
288665 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7879 usd
CY2022Q3 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
106226 usd
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
137337 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172201 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
174096 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1148246 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
616977 usd
CY2022Q3 us-gaap Assets
Assets
9936621 usd
CY2021Q4 us-gaap Assets
Assets
9001674 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
371794 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
258764 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24468 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26370 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1266878 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1576000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
55688 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
51046 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
438022 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1718828 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2350202 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113770 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124114 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
191000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
2023598 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2474316 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4622 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4522 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2064060 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1988137 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6077940 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4768298 usd
CY2022Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
8146622 usd
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
6760957 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
233599 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
233599 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7913023 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6527358 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9936621 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9001674 usd
CY2022Q3 us-gaap Revenues
Revenues
2301329 usd
CY2021Q3 us-gaap Revenues
Revenues
1449881 usd
us-gaap Revenues
Revenues
8112167 usd
us-gaap Revenues
Revenues
5073900 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
865684 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
407174 usd
us-gaap Cost Of Revenue
CostOfRevenue
3129197 usd
us-gaap Cost Of Revenue
CostOfRevenue
1201035 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1435645 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
1042707 usd
us-gaap Gross Profit
GrossProfit
4982970 usd
us-gaap Gross Profit
GrossProfit
3872865 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1093530 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
753980 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3313336 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2638547 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
342115 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
288727 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1669634 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1234318 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10611 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
26511 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
11584 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
82897 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
71635 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
368626 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
243311 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1763142 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1248953 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78500 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56500 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
453500 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
292500 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
290126 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
186811 usd
us-gaap Net Income Loss
NetIncomeLoss
1309642 usd
us-gaap Net Income Loss
NetIncomeLoss
956453 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4511988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4508258
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4566679
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4526115
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4560604
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4522694
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4693493 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13006 usd
CY2021Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
0 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
616007 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5322506 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45187 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
153635 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5521328 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21051 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
186811 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5729190 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6527358 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13707 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1261840 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7802905 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31158 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-242324 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7591739 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31158 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
290126 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7913023 usd
us-gaap Net Income Loss
NetIncomeLoss
1309642 usd
us-gaap Net Income Loss
NetIncomeLoss
956453 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7879 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20012 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
200000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-222000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
76023 usd
us-gaap Share Based Compensation
ShareBasedCompensation
79244 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-57000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1362805 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
277353 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
198213 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-141317 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-388665 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-123465 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-29304 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
189314 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
109223 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
184829 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1902 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2379 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-309122 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
844141 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
520649 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-491795 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-271955 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2211968 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
57000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
473400 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
473400 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-271955 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2628368 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4945913 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1731869 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4673958 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4360237 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
12047 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
48237 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
44437 usd
CY2022Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2926000 usd
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1438000 usd
CY2022Q3 tbtc Revenue Recognized On Contract With Customer
RevenueRecognizedOnContractWithCustomer
1079000 usd
CY2022Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
869819 usd
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
288665 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s use of estimates and assumptions include: for revenue recognition, the nature and timing of satisfaction of performance obligations, and determining the standalone selling price (“SSP”) of performance obligations, determining collectability, and other obligations, realizability of accounts receivable, the valuation of investments, the valuation of deferred tax assets and liabilities, and inventory valuation. Actual results could differ from those estimates, and the difference could be significant.  For further information about our critical accounting estimates, see the discussion in Item <em style="font: inherit;">7,</em> “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” under the heading “Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2021.</em></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">There were <em style="font: inherit;">no</em> changes in critical accounting estimates or assumptions for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2022</em>.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company’s significant accounting policies are described in Note <em style="font: inherit;">1</em> of the financial statement included in its Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2021</em>.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Concentrations of Risk</span></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company maintains its cash balances at <em style="font: inherit;">two</em> financial institutions. Accounts are insured by the Federal Deposit Insurance Corporation (FDIC) up to <em style="font: inherit;">$250,000.</em> At times throughout the year, the Company’s cash balances exceeded amounts insured by the FDIC. The Company doesn’t believe it is exposed to any significant credit risk on its cash balances.  Cash equivalents represent money market funds or short-term investments with original maturities of <em style="font: inherit;">three</em> months or less from the date of purchase.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p>
CY2022Q3 us-gaap Revenues
Revenues
2301329 usd
CY2021Q3 us-gaap Revenues
Revenues
1449881 usd
CY2022Q3 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2021Q3 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
us-gaap Revenues
Revenues
8112167 usd
us-gaap Revenues
Revenues
5073900 usd
tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
121181 usd
CY2021Q4 tbtc Receivable Employee Retention Credit
ReceivableEmployeeRetentionCredit
122000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
999 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
36353 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1780571 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1582358 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
440856 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
699024 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1799184 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1017533 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
190713 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8839 usd
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1734789 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1078909 usd
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
121181 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
56786 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
77623 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4590 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16247 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
56786 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 usd
CY2021Q1 tbtc Lessor Salestype Lease Implied Interest Rate
LessorSalestypeLeaseImpliedInterestRate
0.06 pure
CY2021Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
210782 usd
CY2021Q1 tbtc Inventory Derecognized For Sales Type Leases
InventoryDerecognizedForSalesTypeLeases
139521 usd
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
29304 usd
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
71261 usd
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
7370 usd
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
15232 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
12225 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
48900 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
48900 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
48900 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
4075 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
163000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
15598 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
147402 usd
CY2022Q3 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
147402 usd
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
176706 usd
CY2022Q3 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
41176 usd
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39369 usd
CY2022Q3 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
106226 usd
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
137337 usd
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.05 pure
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15662 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
48237 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
14504 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
43512 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
16039 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
64666 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65682 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
36620 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
183008 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10807 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
172201 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M13D
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
320000 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70000
CY2021Q2 tbtc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
128726 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
22919 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M20D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
122050 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
50000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.60
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
68150 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
70000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
290126 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
186811 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4511988
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4566679
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4526115
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1309642 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
956453 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4508258
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4560604
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4522694
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44700
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
38600

Files In Submission

Name View Source Status
0001437749-22-026747-index-headers.html Edgar Link pending
0001437749-22-026747-index.html Edgar Link pending
0001437749-22-026747.txt Edgar Link pending
0001437749-22-026747-xbrl.zip Edgar Link pending
ex_420287.htm Edgar Link pending
ex_420288.htm Edgar Link pending
ex_420289.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbltrc20220930_10q.htm Edgar Link pending
tbtc-20220930.xsd Edgar Link pending
tbtc-20220930_cal.xml Edgar Link unprocessable
tbltrc20220930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tbtc-20220930_def.xml Edgar Link unprocessable
tbtc-20220930_pre.xml Edgar Link unprocessable
tbtc-20220930_lab.xml Edgar Link unprocessable